Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.94M Buy
4,071
+171
+4% +$85.7K 0.15% 126
2022
Q2
$1.86M Sell
3,900
-579
-13% -$323K 0.14% 141
2022
Q1
$2.99M Buy
4,479
+844
+23% +$565K 0.2% 108
2021
Q4
$2.89M Sell
3,635
-53
-1% -$42.1K 0.19% 116
2021
Q3
$2.75M Sell
3,688
-190
-5% -$149K 0.2% 110
2021
Q2
$2.68M Buy
3,878
+256
+7% +$169K 0.2% 108
2021
Q1
$2.24M Sell
3,622
-285
-7% -$158K 0.19% 108
2020
Q4
$1.91M Buy
3,907
+1,877
+92% +$790K 0.19% 114
2020
Q3
$749K Buy
2,030
+26
+1% +$9.72K 0.09% 196
2020
Q2
$738K Buy
+2,004
New +$629K 0.09% 202

Other funds holding ASML

Corient Capital Partners's ASML Position: Q3 2022 in Review

Corient Capital Partners increased its ASML (ASML) stake by 4.4% in Q3 2022, buying an estimated $85.7K and bringing the position to 4,071 shares worth $1.94M. The position accounts for 0.15% of the portfolio, ranked #126.

Corient Capital Partners first reported a position in ASML in Q2 2020 and has held it in 10 quarters since. The position peaked at $2.99M in Q1 2022. 884 funds tracked by Wall St. Rank hold ASML as of Q3 2022.

  • Corient Capital Partners held 4,071 shares of ASML worth $1.94M as of Q3 2022.
  • Corient Capital Partners bought 171 ASML shares in Q3 2022, an estimated $85.7K.
  • ASML made up 0.15% of Corient Capital Partners's portfolio in Q3 2022, its #126 holding.
  • Corient Capital Partners first reported a position in ASML in Q2 2020 and has held it in 10 quarters since.
  • Corient Capital Partners's ASML position peaked at $2.99M in Q1 2022.
  • 884 funds tracked by Wall St. Rank held ASML as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.